Clinical efficacy of famotidine in the treatment of acid-related diseases: an overview
- PMID: 2210612
Clinical efficacy of famotidine in the treatment of acid-related diseases: an overview
Abstract
The clinical efficacy of famotidine has been clearly shown in the short- and long-term treatment of a number of acid-related diseases such as duodenal and gastric ulcer as well as in the acute management of reflux esophagitis. In addition, famotidine effectively treats anastomotic ulcer and nonulcer dyspepsia. Based on a number of considerations--chemical structure, pharmacokinetics, pharmacodynamics, clinical efficacy, tolerability, and dosage regimen--famotidine represents an end-point in the development of the H2-antagonist group of anti-ulcer agents.
Similar articles
-
[Famotidine in the treatment of duodenal peptic ulcer].Rev Gastroenterol Peru. 1990;10(1):27-32. Rev Gastroenterol Peru. 1990. PMID: 2129891 Clinical Trial. Spanish.
-
Clinical review of lansoprazole.Br J Clin Pract Suppl. 1994 May-Jun;75:48-55; discussion 56-7. Br J Clin Pract Suppl. 1994. PMID: 8060802 Review.
-
Famotidine in the USA: a review of efficacy studies.J Int Med Res. 1989;17 Suppl 1:17A-24A. J Int Med Res. 1989. PMID: 2566539 Review.
-
[Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].Eksp Klin Gastroenterol. 2002;(4):30-3, 131. Eksp Klin Gastroenterol. 2002. PMID: 12503271 Clinical Trial. Russian.
-
Omeprazole: a comprehensive review.Pharmacotherapy. 1993 Jan-Feb;13(1):46-59. Pharmacotherapy. 1993. PMID: 8437967 Review.
Cited by
-
The growth capacity of hematopoietic progenitor cells in severe neutropenia induced by famotidine.Ann Hematol. 1992 May;64(5):231-9. doi: 10.1007/BF01738302. Ann Hematol. 1992. PMID: 1623058
-
An overview of famotidine polymorphs: solid-state characteristics, thermodynamics, polymorphic transformation and quality control.Pharm Res. 2014 Jul;31(7):1619-31. doi: 10.1007/s11095-014-1323-5. Epub 2014 Mar 1. Pharm Res. 2014. PMID: 24577998 Review.